No Routine Medications Are Recommended for Acute Cough
For acute cough in immunocompetent adults, do not routinely prescribe any medications—including antitussives, expectorants, antihistamines, decongestants, bronchodilators, corticosteroids, NSAIDs, or antibiotics—as none have proven effectiveness in reducing cough severity or duration 1.
The Evidence Against Routine Treatment
The 2020 CHEST Expert Panel guideline provides the strongest and most recent evidence on this topic. Their systematic review found insufficient evidence to support routine use of any pharmacological therapy for acute bronchitis-related cough 1. Specifically:
- Antibiotics: A multicenter RCT comparing amoxicillin-clavulanic acid to placebo showed no difference in cough duration (11 days vs 11 days) 1
- NSAIDs: Ibuprofen 600mg TID showed no benefit over placebo (9 days vs 11 days of frequent cough, not statistically significant) 1
- Antitussives, bronchodilators, and corticosteroids: No evidence of benefit 1
A 2014 Cochrane review of 29 trials (4,835 patients) reinforced these findings, concluding there is "no good evidence for or against the effectiveness of OTC medicines in acute cough" 2.
When to Reconsider
Reassess and consider antibiotics only if the cough worsens AND you suspect a complicating bacterial infection 1. This is a clinical judgment call based on:
- Worsening symptoms rather than improvement
- Development of high fever, purulent sputum with systemic signs
- Prolonged duration beyond expected viral course
Critical Differential Diagnoses to Rule Out
Before accepting "acute bronchitis" as the diagnosis, actively exclude conditions that DO require specific treatment 1:
- Asthma exacerbation or cough-variant asthma (may need bronchodilators/corticosteroids)
- COPD exacerbation (may need corticosteroids/antibiotics)
- Bronchiectasis exacerbation
- Bacterial sinusitis
- Pneumonia (requires antibiotics)
Limited Exceptions Based on Lower-Quality Evidence
While the guideline recommends against routine use, some research suggests potential benefit from:
- Honey (for children ≥1 year): More effective than placebo over 3 days 2
- Zinc: Some evidence in adults 3
- Intranasal ipratropium: For rhinorrhea-associated cough 3
However, these are not part of the primary guideline recommendations.
Common Pitfalls to Avoid
Prescribing antibiotics for viral acute bronchitis: The most common error. Studies show 53-62% of patients receive antibiotics despite lack of benefit 4
Using combination products without evidence: Fixed-dose combinations are widely prescribed (particularly in some countries) but lack supporting evidence 4
Treating without excluding mimics: Many conditions present similarly but require different management 1
Over-the-counter medications in children <4 years: Should not be used 3
What to Tell Patients
Set appropriate expectations: acute viral cough typically lasts 8-11 days and is self-limiting 1. Good hand hygiene prevents transmission 3. Symptomatic relief without medication is the standard of care. Schedule reassessment if symptoms worsen or persist beyond 3 weeks.